PEPTIDE RECEPTOR RADIONUCLIDE THERAPY FOR METASTATIC MEDULLARY THYROID CARCINOMA: A WESTERN AUSTRALIAN EXPERIENCE

被引：0
|
作者：
Pugazhenthi, Kamali [1 ]
机构：
[1] Fiona Stanley Hosp, Murdoch, WA, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2023年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [21] NEW RADIONUCLIDE TRACERS FOR THE DIAGNOSIS AND THERAPY OF MEDULLARY-THYROID CARCINOMA
    HOEFNAGEL, CA
    DELPRAT, CC
    ZANIN, D
    VANDERSCHOOT, JB
    CLINICAL NUCLEAR MEDICINE, 1988, 13 (03) : 159 - 165
  • [22] Peptide Receptor Radionuclide Therapy in Patients With Advanced Progressive Medullary Thyroid Cancer Efficacy, Safety, and Survival Predictors
    Liu, Qingxing
    Kulkarni, Harshad R.
    Zhao, Tianzhi
    Schuchardt, Christiane
    Chen, Xiaoyuan
    Zhu, Zhaohui
    Zhang, Jingjing
    Baum, Richard P.
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (03) : 221 - 227
  • [23] Peptide Receptor Radionuclide Therapy Using 177Lu and 90Y-DOTATATE in Metastatic Treatment-Refractory Medullary Thyroid Cancer
    Puranik, A.
    Baum, R. P.
    Kulkarni, H.
    Singh, A.
    Rangarajan, V
    Agrawal, A.
    Shah, S.
    Purandare, N.
    NEUROENDOCRINOLOGY, 2019, 108 : 228 - 228
  • [24] Peptide Receptor Radionuclide Therapy (PRRT) for Metastatic Neuroendocrine Tumors (NETs): A United States Experience
    Katona, Bryson
    Riff, Brian
    Soulen, Michael
    Pryma, Daniel
    Bennett, Bonita
    Wild, Damian
    Nicolas, Guillaume
    Teitelbaum, Ursina
    Metz, David
    PANCREAS, 2017, 46 (03) : 439 - 439
  • [25] Cure of Neuroendocrine Carcinoma by Peptide Receptor Radionuclide Therapy
    Zoephel, Klaus
    Strumpf, Annette
    Wunderlich, Gerd
    Oehme, Liane
    Eisenhofer, Graeme
    Kotzerke, Joerg
    CLINICAL NUCLEAR MEDICINE, 2008, 33 (10) : 690 - 691
  • [26] Combination of peptide receptor radionuclide therapy and immune checkpoint inhibitor in metastatic Merkel cell carcinoma
    Moghadam, Soroush Zarehparvar
    Manafi-Farid, Reyhaneh
    Nghiem, Paul
    Gunnell, Lindsay
    Askari, Emran
    IRANIAN JOURNAL OF NUCLEAR MEDICINE, 2024, 32 (01): : 99 - 101
  • [27] Metastatic Growth Hormone Secreting Pituitary Carcinoma Treated with Peptide Receptor Radionuclide Therapy.
    Kassem, S.
    Gross, D. J.
    Doviner, V.
    Dresner-Pollak, R.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [28] PEPTIDE RECEPTOR RADIONUCLIDE THERAPY FOR METASTATIC PANCREATIC NEUROENDOCRINE TUMOR
    Potter, Samara
    Johnston, Danielle
    Mahajan, Priya
    Venkatramani, Rajkumar
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [29] The role of radionuclide therapy in medullary thyroid cancer
    Castellani, MR
    Alessi, A
    Savelli, G
    Bombardieri, E
    TUMORI, 2003, 89 (05) : 560 - 562
  • [30] Hereditary medullary thyroid carcinoma syndromes: experience from western India
    Diwaker, Chakra
    Sarathi, Vijaya
    Jaiswal, Sanjeet Kumar
    Shah, Ravikumar
    Deshmukh, Anuja
    Thomas, Anand Ebin
    Prakash, Gagan
    Malhotra, Gaurav
    Patil, Virendra
    Lila, Anurag
    Shah, Nalini
    Bandgar, Tushar
    FAMILIAL CANCER, 2021, 20 (03) : 241 - 251
12345